Dialysis providers oppose longer coverage of kidney transplant drugs

12/15/2009 | NYTimes.com

The National Kidney Foundation joined drugmakers and dialysis providers in opposing a measure in Congress that would extend Medicare coverage beyond 36 months for immunosuppressant drugs given to patients after a kidney transplant because they say it would be paid for by reducing reimbursements to dialysis patients. Kidney Care Partners, a coalition of dialysis providers, drugmakers and others, said although the bundled-payment method would help one group of patients, it "would potentially put another very vulnerable group of patients at risk."

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC